07/02/2021
8:15 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2021
6:49 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2021
4:14 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2021
5:53 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2021
5:48 PM | Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2021
7:12 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2021
6:24 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2021
3:10 PM | Acceleron Pharma (Filer)
| Form DEFA14A
| |
04/05/2021
7:27 PM | Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2021
7:17 PM | Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/05/2021
6:22 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2021
5:08 PM | Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2021
5:00 PM | Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2021
4:17 PM | Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
3:17 PM | Acceleron Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2021
3:11 PM | Acceleron Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/08/2021
9:15 AM | Acceleron Pharma (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
02/04/2021
6:21 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2021
6:50 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
6:46 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
6:42 PM | Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
6:35 PM | Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
| Form 4/A
| |
02/02/2021
6:15 PM | Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
6:10 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
6:00 PM | Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
5:52 PM | Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
5:49 PM | Acceleron Pharma (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
5:46 PM | Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
5:41 PM | Acceleron Pharma (Issuer)
Kearney Terrence C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
5:38 PM | Acceleron Pharma (Issuer)
Hite Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
5:31 PM | Acceleron Pharma (Issuer)
Hamill Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
5:26 PM | Acceleron Pharma (Issuer)
Nader Francois (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2021
6:11 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2021
6:12 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2021
6:09 PM | Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2021
6:05 PM | Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2021
6:03 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2021
5:58 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2020
5:24 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2020
5:24 PM | Acceleron Pharma (Issuer)
Acceleron Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2020
5:08 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2020
9:05 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2020
3:14 PM | Acceleron Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2020
3:08 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2020
6:27 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2020
6:14 PM | Acceleron Pharma (Issuer)
Kearney Terrence C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2020
10:07 AM | Acceleron Pharma (Filer)
| Form CT ORDER
| |
10/02/2020
6:56 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2020
8:23 AM | Acceleron Pharma (Issuer)
Hamill Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2020
8:13 AM | Acceleron Pharma (Issuer)
Hamill Laura (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/16/2020
4:27 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2020
3:51 PM | Acceleron Pharma (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2020
9:03 AM | Acceleron Pharma (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
09/09/2020
4:49 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2020
3:07 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2020
6:30 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2020
5:27 PM | Acceleron Pharma (Issuer)
BRISTOL MYERS SQUIBB CO (Reporting)
CELGENE CORP /DE/ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2020
5:57 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2020
4:24 PM | Acceleron Pharma (Issuer)
BRISTOL MYERS SQUIBB CO (Reporting)
CELGENE CORP /DE/ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2020
4:22 PM | Acceleron Pharma (Issuer)
BRISTOL MYERS SQUIBB CO (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/26/2020
4:22 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2020
2:17 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2020
7:32 PM | Acceleron Pharma (Issuer)
Hite Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2020
7:23 PM | Acceleron Pharma (Issuer)
Hite Christopher (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/04/2020
4:17 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2020
3:14 PM | Acceleron Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2020
3:10 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2020
4:06 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2020
4:30 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2020
4:29 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2020
4:26 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2020
3:39 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/06/2020
7:41 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2020
3:13 PM | Acceleron Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2020
3:10 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2020
8:26 AM | Acceleron Pharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/10/2020
5:01 PM | Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
| Form 4/A
| |
02/10/2020
4:50 PM | Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
| Form 4/A
| |
01/27/2020
3:14 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2020
6:32 PM | Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:59 PM | Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:48 PM | Acceleron Pharma (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:45 PM | Acceleron Pharma (Issuer)
Kearney Terrence C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:41 PM | Acceleron Pharma (Issuer)
George Jean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:37 PM | Acceleron Pharma (Issuer)
Nader Francois (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:33 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:27 PM | Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:21 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:18 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2020
3:20 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2020
3:36 PM | Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:51 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:48 PM | Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:45 PM | Acceleron Pharma (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:41 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:37 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:32 PM | Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:24 PM | Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:20 PM | Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/17/2019
5:39 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
